CONSTELLA
Identification of Constella
| No description |
Google image searchProduct monograph
Active ingredient
linaclotide, 290 MCG
DIN: 02417170
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 15-DEC-2023
ATC:
- A06 — LAXATIVES (ATC, ATC/DDD, )
- A06A — LAXATIVES (ATC, ATC/DDD)
- A06AX — Other laxatives (ATC, ATC/DDD)
- A06AX04 — LINACLOTIDE (ATC/DDD)
Reference brand drug: Constella
